MILAN (Reuters) – Almost 99% people who have died of COVID-19 in Italy since February this year were not fully vaccinated, the National Health Institute (ISS) said on Tuesday. The study, contained...

BERLIN (Reuters) – BioNTech wants to build on its success in COVID-19 by developing the first vaccine for malaria based on mRNA technology and aims to start clinical testing by the end on 2022, in...

FILE PHOTO: Bottles of the Sinovac vaccine are seen at a hospital, as Indonesia drives mass vaccination for the coronavirus disease (COVID-19), in Jakarta, Indonesia, January 21, 2021. REUTERS/Willy KurniawanBEIJING...

Total antibody levels appear to start declining from as early as six weeks after complete vaccination and can reduce by more than 50% over 10 weeks, according to new data from UCL’s Virus Watch...

Israeli government says Pfizer’s COVID-19 vaccine provides ‘significantly less’ protection against the Indian ‘Delta’ variant than health officials had hoped Israel says...

The COVID-19 pandemic continues apace, with high- and lower-income settings struggling to contain outbreaks. The vaccine rollout is relatively speedy in some countries such as the UK. However, vaccine...

JOHANNESBURG (Reuters) -Standard Chartered Bank said on Thursday it is providing $200 million in not-for-profit funding to the African Export-Import Bank’s (Afreximbank) COVID-19 vaccine procurement...

Israel on Monday began administering a third shot of the Pfizer/BioNTech coronavirus vaccine to patients with compromised immune systems, as cases in the country rise, the health ministry said. Those...

A vaccine to protect against infection with hepatitis C could be in use within 5 years, says Professor Sir Michael Houghton, who won the Nobel Prize for Medicine and Physiology along with three other...

BREAKING NEWS: Moderna says its COVID-19 vaccine DOES work against variants including Indian ‘Delta’ strain after lab tests Moderna Inc looked at blood samples of eight patients one week after...